Published in Rev Rhum Engl Ed on October 01, 1997
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol (2001) 4.34
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev (1999) 4.02
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic (1987) 3.40
Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster. Science (2001) 2.78
SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum (1999) 2.70
HIV infection en route to endogenization: two cases. Clin Microbiol Infect (2014) 2.63
Biology of aerobic carbon monoxide-oxidizing bacteria. Annu Rev Microbiol (1983) 2.52
Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost (2000) 2.45
Reisolation of the carbon monoxide utilizing hydrogen bacterium Pseudomonas carboxydovorans (Kistner) comb. nov. Arch Microbiol (1978) 2.39
Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol (1988) 2.28
Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) (2006) 2.15
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11
Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol (1999) 2.09
Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem (2001) 2.08
Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand (2002) 2.02
Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum (2001) 2.00
Skin pigmentary anomalies and mosaicism for an acentric marker chromosome originating from 3q. J Med Genet (1999) 2.00
Two membrane-associated NiFeS-carbon monoxide dehydrogenases from the anaerobic carbon-monoxide-utilizing eubacterium Carboxydothermus hydrogenoformans. J Bacteriol (2001) 2.00
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum (2008) 1.90
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum (2009) 1.88
Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.87
Subungual glomus tumors: evaluation with MR imaging. Radiology (1995) 1.86
Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol (1996) 1.85
Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med (1998) 1.72
Pain in sciatica depresses lower limb nociceptive reflexes to sural nerve stimulation. J Neurol Neurosurg Psychiatry (1987) 1.71
Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients. Clin Infect Dis (1994) 1.69
Carbon monoxide:methylene blue oxidoreductase from Pseudomonas carboxydovorans. J Bacteriol (1980) 1.68
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
[Erysipelas: epidemiological, clinical and therapeutic data (111 cases)]. Ann Dermatol Venereol (1991) 1.66
Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol (2001) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
Role of carboxydobacteria in consumption of atmospheric carbon monoxide by soil. Appl Environ Microbiol (1981) 1.62
Oxidation of carbon monoxide in cell extracts of Pseudomonas carboxydovorans. J Bacteriol (1979) 1.61
Crystal structure and mechanism of CO dehydrogenase, a molybdo iron-sulfur flavoprotein containing S-selanylcysteine. Proc Natl Acad Sci U S A (1999) 1.60
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther (2007) 1.58
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Why the "SAPHO" syndrome? J Rheumatol (1995) 1.52
Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol (1995) 1.50
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol (2001) 1.49
Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol (1995) 1.46
Chemical and spectral properties of carbon monoxide: methylene blue oxidoreductase. The molybdenum-containing iron-sulfur flavoprotein from Pseudomonas carboxydovorans. J Biol Chem (1982) 1.45
Sequence analysis, characterization and CO-specific transcription of the cox gene cluster on the megaplasmid pHCG3 of Oligotropha carboxidovorans. Gene (1999) 1.43
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum (2009) 1.43
A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum (2001) 1.43
[Unsatisfactory results of intradiscal injection of triamcinolone hexacetonide in the treatment of sciatica caused by intervertebral disk herniation]. Presse Med (1992) 1.42
Reliability of epidural pressure measurement in clinical practice: behavior of three modern sensors during simultaneous ipsilateral intraventricular or intraparenchymal pressure measurement. Neurosurgery (1998) 1.41
[Apropos of recommendations concerning oral treatment of acne. An interview with the president S. Belaich. Interview by Hélne Allouch]. Presse Med (1999) 1.40
Ankylosing spondylitis with exuberant sclerosis in the sacroiliac joints, symphysis pubis and spine. J Rheumatol (1991) 1.40
[Chronic enterocolopathies and SAPHO syndrome. 8 cases]. Rev Rhum Mal Osteoartic (1992) 1.40
IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. J Rheumatol (2000) 1.39
Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. Ann Rheum Dis (1993) 1.39
Molecular characterization of the gene cluster coxMSL encoding the molybdenum-containing carbon monoxide dehydrogenase of Oligotropha carboxidovorans. J Bacteriol (1995) 1.35
Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis (2004) 1.35
Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol (2003) 1.32
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol (1997) 1.32
Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res (2001) 1.31
Tuberculosis of the sacroiliac joint: clinical features, outcome, and evaluation of closed needle biopsy in 11 consecutive cases. Am J Med (1988) 1.30
The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.30
Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis (2004) 1.29
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br J Pharmacol (2007) 1.28
Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev (2000) 1.28
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Homology and distribution of CO dehydrogenase structural genes in carboxydotrophic bacteria. Arch Microbiol (1989) 1.27
[Detection of serum anti-deoxyribonucleic acid antibodies by Farr's radioimmunoassay]. Nouv Presse Med (1974) 1.25
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Immunocytochemical localization of carbon monoxide oxidase in Pseudomonas carboxydovorans. The enzyme is attached to the inner aspect of the cytoplasmic membrane. J Biol Chem (1984) 1.25
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol (1999) 1.25
Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Intern Med (1992) 1.24
Partition coefficient of a surfactant between aggregates and solution: application to the micelle-vesicle transition of egg phosphatidylcholine and octyl beta-D-glucopyranoside. Biophys J (1995) 1.22
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Selenium in biology: facts and medical perspectives. Biol Chem (2001) 1.21
Carbon monoxide dehydrogenase activity in Bradyrhizobium japonicum. Appl Environ Microbiol (2000) 1.21
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol (2002) 1.19
Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol (1997) 1.16
1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis (2006) 1.16
Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) (2008) 1.15
Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis. Proc R Soc Med (1967) 1.14
Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol (1994) 1.14
A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis (1996) 1.13
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum (1994) 1.12
The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum (2008) 1.11